Susquehanna International Group’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,553
Closed -$23.3K 12511
2024
Q4
$61.5K Buy
3,553
+2,733
+333% +$46.7K ﹤0.01% 11593
2024
Q3
$22.3K Buy
820
+13
+2% +$404 ﹤0.01% 11605
2024
Q2
$32.8K Sell
807
-450
-36% -$24.7K ﹤0.01% 11538
2024
Q1
$83.7K Buy
1,257
+557
+80% +$41.6K ﹤0.01% 11316
2023
Q4
$79.4K Sell
700
-1,726
-71% -$180K ﹤0.01% 11481
2023
Q3
$441K Buy
2,426
+1,510
+165% +$396K ﹤0.01% 8525
2023
Q2
$335K Buy
916
+271
+42% +$122K ﹤0.01% 9207
2023
Q1
$430K Buy
645
+371
+135% +$330K ﹤0.01% 8922
2022
Q4
$240K Sell
274
-639
-70% -$804K ﹤0.01% 9669
2022
Q3
$1M Sell
913
-149
-14% -$197K ﹤0.01% 6629
2022
Q2
$880K Sell
1,062
-366
-26% -$377K ﹤0.01% 6842
2022
Q1
$2.21M Sell
1,428
-39
-3% -$52.6K ﹤0.01% 5252
2021
Q4
$2.63M Buy
1,467
+54
+4% +$144K ﹤0.01% 4894
2021
Q3
$4.66M Sell
1,413
-1,767
-56% -$6.18M ﹤0.01% 4077
2021
Q2
$14M Sell
3,180
-1,062
-25% -$4.19M ﹤0.01% 2451
2021
Q1
$20.6M Buy
4,242
+4,224
+23,467% +$23.8M ﹤0.01% 1837
2020
Q4
$34K Buy
+18
New +$6.73K ﹤0.01% 10821

Other funds holding BNGO

Susquehanna International Group's BNGO Position: Q1 2025 in Review

Susquehanna International Group sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 3,553 shares — an estimated $23.3K sold.

Susquehanna International Group first reported a position in BNGO in Q4 2020 and held it in 17 quarters. The position peaked at $20.6M in Q1 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Susquehanna International Group reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • Susquehanna International Group sold 3,553 Bionano Genomics shares in Q1 2025, an estimated $23.3K.
  • Susquehanna International Group first reported a position in Bionano Genomics in Q4 2020 and held it in 17 quarters.
  • Susquehanna International Group's Bionano Genomics position peaked at $20.6M in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.